Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DR REDDYS LABORATORIES LTD Capital/Financing Update 2024

May 6, 2024

30528_rns_2024-05-06_7ee3a72c-2686-4160-869c-4766b363758e.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

May 6, 2024

National Stock Exchange of India Ltd. (Scrip Code: DRREDDY-EQ) BSE Ltd. (Scrip Code: 500124) New York Stock Exchange Inc. (Stock Code: RDY) NSE IFSC Ltd. (Stock Code: DRREDDY)

Dear Sir/Madam,

Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015

This is to inform that the Nomination, Governance and Compensation Committee of the Board of Directors of the Company at its meeting held on May 6, 2024, has approved the grant of stock options to the eligible employees under the Employees Stock Option Schemes of the Company:

Sl. Typeof Number Value Exercise ESOP Scheme
No. Option(s) of options Priceper
granted share
1 IndianStock *1,37,160 Fair Market Rs. 6,350/- Dr. Reddy's
Options # Value Employees Stock
3,210 Option Scheme, 2018
2 American *54,462 Fair Market Rs. 6,350/- Dr. Reddy's
Depository Value Employees
Receipts ADR Stock Option
(ADRs) Stock Scheme, 2007
Options

* 100% vesting at the end of 3 years. #Equally graded vesting in 3 years.

This is for your information and records.

Thanking you.

Yours faithfully, For Dr. Reddy's Laboratories Limited

KUMAR RANDHIR SINGH

Digitally signed by KUMAR RANDHIR SINGH Date: 2024.05.06 18:19:45 +05'30'

K. Randhir Singh Company Secretary, Compliance Officer & Head-CSR